Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in LIMNW held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | ARISTEIA CAPITAL LLC | 320K | $16K | 0.0% | 4.443% | 0.00% |
| 2 | LINDEN ADVISORS LP | 268K | $13K | 0.0% | 3.729% | 0.00% |
| 3 | Saba Capital Management, L.P. | 234K | $11K | 0.0% | 3.250% | 0.00% |
| 4 | Polar Asset Management Partners Inc. | 123K | $6K | 0.0% | 1.706% | 0.00% |
| 5 | MOORE CAPITAL MANAGEMENT, LP | 125K | $5K | 0.0% | 1.738% | 0.00% |
| 6 | MMCAP International Inc. SPC | 112K | $4K | 0.0% | 1.554% | 0.00% |
| 7 | D. E. Shaw & Co., Inc. | 83K | $3K | 0.0% | 1.159% | 0.00% |
| 8 | Blue Owl Capital Holdings LP | 50K | $2K | 0.0% | 0.695% | 0.00% |
| 9 | PERISCOPE CAPITAL INC. | 48K | $2K | 0.0% | 0.660% | 0.00% |
| 10 | WOLVERINE ASSET MANAGEMENT LLC | 39K | $2K | -37.3% | 0.547% | 0.00% |
| 11 | TORONTO DOMINION BANK | 35K | $1K | 0.0% | 0.488% | 0.00% |
| 12 | LMR Partners LLP | 30K | $1K | 0.0% | 0.417% | 0.00% |
| 13 | Arena Capital Advisors, LLC- CA | 29K | $1K | 0.0% | 0.406% | 0.00% |
| 14 | JANE STREET GROUP, LLC | 24K | $971 | 0.0% | 0.338% | 0.00% |
| 15 | Limestone Investment Advisors LP | 23K | $902 | 0.0% | 0.314% | 0.00% |
| 16 | GTS SECURITIES LLC | 21K | $841 | -29.2% | 0.292% | 0.00% |
| 17 | DUPONT CAPITAL MANAGEMENT CORP | 6K | $306 | 0.0% | 0.087% | 0.00% |
| 18 | UBS Group AG | 5K | $180 | +7.0% | 0.063% | 0.00% |
| 19 | HGC Investment Management Inc. | 1K | $50 | 0.0% | 0.017% | 0.00% |
| 20 | Clear Street Group Inc. | 100 | $4 | -100.0% | 0.001% | 0.00% |
| 21 | FLOW TRADERS U.S. LLC | 13K | $1 | 0.0% | 0.182% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in LIMNW — a direct measure of their conviction.
Filings activity in LIMNW during Q1 2026, grouped by how each filer changed its position.
4 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 21 | 16% | 9.95% | 3.26 pp | $0M | 25% |
| Q4 2025 | 25 | 7.4% | 13.21% | 42.18 pp | $0M | 76% |
| Q3 2025 | 27 | +3.8% | 55.39% | 60.57 pp | $0M | 52% |
| Q2 2025 | 26 | — | 115.96% | — | $1M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying LIMNW stock.
Based on Q1 2026 13F filings, institutional ownership of Liminatus Pharma, Inc. Warrants stands at 10.0%, held across 21 reporting institutions.
ARISTEIA CAPITAL LLC is the largest reported institutional holder of LIMNW, with approximately 319,510 shares worth $0.00B as of Q1 2026.
Yes — 1 widely-followed marquee investor appear among the top 25 institutional holders of LIMNW, including JANE STREET GROUP, LLC.
Our composite Smart Money Score for LIMNW is 20 out of 100 (Bearish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
0 institutions opened new positions in LIMNW during Q1 2026, while 4 fully exited. 16 added to existing positions and 3 trimmed.
LIMNW institutional ownership fell by 3.26 percentage points quarter-over-quarter, with a net change of -4 holders.
The top 10 institutions account for 90.2% of all reported 13F value in LIMNW, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Liminatus Pharma, Inc. Warrants (LIMNW) Institutional Ownership